Doctors test new 'Lattice' radiation approach to shrink throat tumors before main treatment
NCT ID NCT07428148
Summary
This study is testing a new treatment approach for advanced throat cancer that hasn't spread to distant organs. Researchers want to see if combining targeted radiation (called 'lattice' radiotherapy) with chemotherapy and immunotherapy can shrink tumors before patients receive their main cancer treatment. The treatment plan will be personalized based on how well the initial therapy works - patients whose tumors shrink significantly will get one type of follow-up treatment, while those with less shrinkage will get another. About 60 people with specific types of advanced throat cancer will participate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.